FOAMCOAT

Post-LOE

aluminum hydroxide; magnesium trisilicate

Guardian Therapeutics

ANDAORALTABLET, CHEWABLE

Approved

Sep 1987

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

FOAMCOAT (aluminum hydroxide; magnesium trisilicate) by Guardian Therapeutics. Approved for heartburn acid indigestion sour stomach upset stomach associated with these symptoms. First approved in 1987.

Drug data last refreshed 18h ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (1)

heartburn acid indigestion sour stomach upset stomach associated with these symptoms

Company

Worked on FOAMCOAT at Guardian Therapeutics? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.